Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;60(7):971-977.
doi: 10.2967/jnumed.118.220541. Epub 2019 Jan 25.

Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes

Affiliations

Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes

Cordula A Jilg et al. J Nucl Med. 2019 Jul.

Abstract

Accurate detection of prostate cancer lymph node metastases (LNM) through PET/CT before lymphadenectomy is crucial for successful therapy. PET/CT with choline derivatives used to be the standard tool for imaging metastases, whereas 68Ga-PSMA (prostate-specific membrane antigen) PET/CT was introduced recently. Both PET techniques were investigated with respect to what extent the detection rate of LNM depends on the size of tumor deposits (TDs) within LNM. Methods: Documenting the switch from the use of 18F-choline to 68Ga-PSMA in 2014, we used 2 patient cohorts undergoing a template lymphadenectomy because of a PET/CT indicating LNM. Forty-four and 40 patients underwent PET/CT with 18F-choline or 68Ga-PSMA ligand, respectively. In total, 226 LNM (125 18F-choline, 101 68Ga-PSMA) originated from 73 salvage lymphadenectomies at biochemical recurrence and from 11 primary lymphadenectomies at radical prostatectomy. LNM eligible for direct correlation of PET/CT to histopathology were identified from lymphadenectomies conducted in small anatomic subregions, with 1 LNM (condition 1) or 1-2 LNM (condition 2). Longitudinal and short diameters of TD within LNM were determined by histopathology, allowing linking of the size of TD in LNM to the detection threshold of PET/CT. Diameters associated with a detection rate of 50% and 90% (d50%, d90%) were calculated on the basis of logistic growth curve models fitted. Results: Gleason score, number of removed LNs, and subregions for lymphadenectomy per patient did not differ significantly between the 18F-choline and 68Ga-PSMA groups. The median prostate-specific antigen level at imaging and number of LNM per patient were significantly higher in the 18F-choline group (3.4 ng/mL, n = 34) than in the 68Ga-PSMA group (2.2 ng/mL, n = 28; both P < 0.05). Longitudinal and short diameters of TD in LNM to reach d90% were 11.2 and 7.4 mm, respectively, for 18F-choline PET/CT and 6.3 and 4.9 mm, respectively, for 68Ga-PSMA PET/CT. Corresponding diameters to reach d50% were 5.5 and 3.3 mm, respectively, for 18F-choline PET/CT and 3.7 and 2.3 mm, respectively, for 68Ga-PSMA PET/CT. Detection rates were significantly higher under 68Ga-PSMA (P = 0.005 and 0.04 for longitudinal and short diameter). Conclusion: 68Ga-PSMA PET/CT is superior to 18F-choline PET/CT in the detection of LNM. Whether those results will lead to an improved patient outcome after 68Ga-PSMA PET-guided therapy needs to be investigated by further studies.

Keywords: PSMA-PET/CT; choline-PET/CT; detection rate; lymph node metastases; prostate cancer.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Workflow with surgery, tissue sample processing, and identification of eligible subregions in men with suspected nodal metastatic PCa undergoing a template lymphadenectomy after PET/CT. Tissue specimens from small anatomic subregions were removed separately at surgery. At histopathology, the size of TDs was determined. Aiming at a direct link from PET/CT to histopathology, subregions fulfilling the requirement for conditions 1 and 2 were selected from 18F-choline and the 68Ga-PSMA PET/CT groups. Finally, size of TDs in detected and undetected LNMs was evaluated for estimation of detection thresholds.
FIGURE 2.
FIGURE 2.
(A–D) Empiric detection rates from 18F-choline PET/CT and the 68Ga-PSMA PET/CT groups for conditions 1 and 2 in dependence on diameter of TD (divided into intervals of 1 mm in length). Dark green line (condition 1) and light green line (condition 2) represent the fitted logistic growth curve model and red line the estimated diameters d90% and d50%, respectively. Longitudinal diameters (A and C) above 10 mm and short diameters (B and D) above 8 mm are shown as 1 group.
FIGURE 3.
FIGURE 3.
Empiric detection rate for condition 1 (A and B) and 2 (C and D) in dependence on diameter of TD. Fitted logistic growth curve models for 18F-choline PET/CT and 68Ga-PSMA PET/CT and P value for difference between the 2 curves are shown.

References

    1. Cornford P, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer: part II—treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2017;71:630–642. - PubMed
    1. Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer: part 1—screening, diagnosis, and local treatment with curative Intent. Eur Urol. 2017;71:618–629. - PubMed
    1. Rauscher I, Maurer T, Beer AJ, et al. Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy. J Nucl Med. 2016;57:1713–1719. - PubMed
    1. Abdollah F, Briganti A, Montorsi F, et al. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy. Eur Urol. 2015;67:839–849. - PubMed
    1. Hövels AM, Heesakkers RA, Adang EM. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63:387–395. - PubMed